EHAB (Enhabit, Inc.) Stock Analysis - Analyst Ratings

Enhabit, Inc. (EHAB) is a publicly traded Healthcare sector company. As of May 20, 2026, EHAB trades at $13.80 with a market cap of $706.91M and a P/E ratio of -153.33. EHAB moved +0.11% today. Year to date, EHAB is +46.50%; over the trailing twelve months it is +30.43%. Its 52-week range spans $6.47 to $14.22. Analyst consensus is neutral with an average price target of $13.80. Rallies surfaces EHAB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate EHAB?

6 analysts cover EHAB: 0 strong buy, 0 buy, 6 hold, 0 sell, and 0 strong sell. The consensus rating is neutral. The average price target is $13.80.

EHAB Key Metrics

Key financial metrics for EHAB
MetricValue
Price$13.80
Market Cap$706.91M
P/E Ratio-153.33
EPS$-0.09
Dividend Yield0.00%
52-Week High$14.22
52-Week Low$6.47
Volume0
Avg Volume0
Revenue (TTM)$1.06B
Net Income$-2.60M
Gross Margin0.00%

EHAB Analyst Consensus

6 analysts cover EHAB: 0 strong buy, 0 buy, 6 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $13.80.

Latest EHAB News

Recent EHAB Insider Trades

  • McQuiddy Collin sold 1.40K (~$19.09K) on Mar 11, 2026.
  • Jolley Julie Diane sold 2.79K (~$38.07K) on Mar 10, 2026.
  • Jolley Julie Diane sold 2.79K (~$38.07K) on Mar 9, 2026.

Common questions about EHAB

What do analysts rate EHAB?
6 analysts cover EHAB: 0 strong buy, 0 buy, 6 hold, 0 sell, and 0 strong sell. The consensus rating is neutral. The average price target is $13.80.
Does Rallies show EHAB price targets?
Yes. Rallies tracks EHAB analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is EHAB research on Rallies investment advice?
No. Rallies provides research, data, and educational context for EHAB. It does not provide personalized investment advice.
EHAB

EHAB